MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Breast Cancer Research and Treatment
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

814 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
814 works in the cohort · of 4,299,418page 2 of 17

Labels cover 3 of 814 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 814 of 814 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Ten-year survival in women with primary stage IV breast cancer
Lee Guek Eng, Shaheenah Dawood, Victoria Sopik, Benjamin Haaland, Pui San Tan, Nirmala Bhoo‐Pathy +4 more
2016· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
137
citations
affno abstractunlabeled
The microbiome and breast cancer: a review
Jennifer Chen, Jacqueline Douglass, Vishnu Prasath, Meghan Neace, Siavash Atrchian, Masoud H. Manjili +2 more
2019· review· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
137
citations
affno abstractunlabeled
FOXA1 is an independent prognostic marker for ER-positive breast cancer
Rutika Mehta, Rohit Jain, Samuel Leung, Jennifer R. Choo, Torsten O. Nielsen, David G. Huntsman +2 more
2011· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
133
citations
affno abstractunlabeled
Breast cancer predisposing alleles in Poland
Bohdan Górski, Cezary Cybulski, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Anna Jakubowska +19 more
2005· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
126
citations
affno abstractunlabeled
A deletion in CHEK2 of 5,395 bp predisposes to breast cancer in Poland
Cezary Cybulski, Dominika Wokołorczyk, Tomasz Huzarski, Tomasz Byrski, Jacek Gronwald, Bohdan Górski +6 more
2006· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
115
citations
afffundno abstractunlabeled
Necrosis and Hypoxia in Invasive Breast Carcinoma
Ladislav Tomes, Ethan Emberley, Yulian Niu, Sandra Troup, Jaromı́r Pastorek, Karen Strange +2 more
2003· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · noneconsensus · none
112
citations
afffundno abstractunlabeled
Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)
Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, J. W. Chapman, Lois E. Shepherd, Timothy J. Whelan +9 more
2018· article· en· Breast Cancer Research and Treatment· Biochemistry, Genetics and Molecular Biology
distilled prediction:candidate · metaepi_narrowconsensus · none
95
citations
← previousnext →

How this was built: Screen · Findings · About